ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Session » Fibromyalgia, Soft Tissue Disorders and Pain I

Meeting: 2013 ACR/ARHP Annual Meeting

Abstract Number: 118
The Controversies and Points Of Debate That Remain a Challenge For Fibromyalgia Care
Abstract Number: 119
Routine Assessment Of Patient Index Data 3 In Fibromyalgia: A Rapid and Reliable Instrument For Evaluating Disease Severity?
Abstract Number: 120
The Symptom Severity In Korean Patients With Fibromyalgia Is Associated With Socioeconomic Status, But Not With Obesity
Abstract Number: 122
Rheumatologists Lack Confidence in Their Knowledge of Cannabinoid Molecules and Use in the Management of Rheumatic Disease Patients: Analysis of a Needs Assessment
Abstract Number: 123
Association Of Rheumatic Diseases With Symptom Severity, Quality Of Life, and Treatment Outcome In Patients With Fibromyalgia
Abstract Number: 124
Disability In Fibromyalgia Is Associated With Greater Self-Reported Symptoms and Functional Impairment
Abstract Number: 125
Correlation Of Findings In Clinical and High Resolution Ultrasonography Examinations Of The Painful Shoulder
Abstract Number: 126
Subgrouping Of Rheumatoid Arthritis Patients Based On Pain, Fatigue, Inflammation and Psychosocial Factors
Abstract Number: 127
Clinical Application Of Pain Diagrams In Fibromyalgia
Abstract Number: 128
Frequency Of Axial Spondyloarthropathy Among Patients Suffering From Fibromyalgia A Magnetic Resonance Immaging  Study With Application Of The Assessment Of Spondylo-Arthritis International Society Classification Criteria
Abstract Number: 129
Identifying Predictors Of A Fibromyalgia Diagnosis: A Retrospective Electronic Medical Record Analysis
Abstract Number: 130
Mindfulness Is Associated With Psychological Symptoms, Self-Efficacy and Quality Of Life Among Patients With Fibromyalgia
Abstract Number: 131
Prevalence and Antecedents Of Fibromyalgia In Elderly Women
Abstract Number: 132
Relation Of Age With Symptom Severity and Quality Of Life In Patients With Fibromyalgia
Abstract Number: 133
Cross-Sectional Neurocognitive Data Do Not Support a Transition From Fibrofog To Alzheimer’s Disease In Fibromyalgia Patients
Abstract Number: 134
Lower Socioeconomic Status Associates With Increased Symptom Severity and Functional Impairment In Fibromyalgia
Abstract Number: 135
Evaluation Of The Quality Of Life and Sleep In Patients With Benign Joint Hypermobility Syndrome
Abstract Number: 136
The Detection Of Primary Hyperparathyroidism In Patients Diagnosed With Fibromyalgia
Abstract Number: 137
A Population-Based Survey and Physician Assessment Of The Characteristics and Prevalence Of Fibromyalgia
Abstract Number: 138
Long Term Outcomes In Fibromyalgia
Abstract Number: 139
Pain and Other Symptoms During The Childhood Of Fibromyalgia Patients
Abstract Number: 140
Fibromyalgia and Pregnancy: Challenges Of The Savella® (Milnacipran) Pregnancy Registry
Abstract Number: 141
Skin Disease and Fibromyalgia: Dermatologic Diagnoses Encountered In a Series Of 845 Patients With Fibromyalgia At Mayo Clinic In 2008
Abstract Number: 142
Home Tender Point Measurement In Fibromyalgia Patients
Abstract Number: 143
Rapid Infrared Microscopy (IRMS) For Differential Diagnosis Of Fibromyalgia and Other Central Sensitivity Syndromes
Abstract Number: 144
Cytokines, Oxidative Stress Markers and Brain-Derived Neurotrophic Factor In Fibromyalgia Syndrome
Abstract Number: 145
Autonomic Nervous System “Decomplexification” In Fibromyalgia. A Proof Of Concept Study Looking At The Fractality Of Heart Rhythms

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified ­­­presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2023 American College of Rheumatology